FarmaIndustrial.com
Supplier business journal of the pharmaceutical industry and technology laboratory
 
nombre y apellidos:
e-mail:
 
 
Novozymes Biopharma secures albucult supply agreement for medical devices
This agreement will result in the launch of the first Class III medical device containing albucult
Date of publication: 25/06/2010 Read more
 
TxCell successfully completes preclinical development of TX-RAD in arthriti
Favorable results mean that TxCell will start a new Phase I/IIa clinical trial
Date of publication: 15/06/2010 Read more
 
Spanish biotech companies in the top three position in successful projects
Tailoring the European Framework Programmes and financing for biotech SMEs: Improvements and Challenges.
Date of publication: 09/06/2010 Read more
 
LSP Announces Acquisition of Portfolio Company FlowCardia, Inc.
Bard is worldwide leader in products that focus on disease state management in three key areas: vascular, urology and oncology
Date of publication: 28/05/2010 Read more
 
Hybrigenics determines the maximum dosage of inecalcitol
Excellent clinical tolerance at high circulating levels broadens therapeutic scope beyond prostate cancer
Date of publication: 20/05/2010 Read more
 
Aragen Bioscience, Inc. and CEVEC Sign License Agreement
License Agreement for Human CAP® and CAP-TTM Technology
Date of publication: 04/05/2010 Read more
 
BioFocus and CHDI Foundation, Inc. enter new five-year collaboration
Collaboration for Huntington’s disease therapeutics. Expands and extends collaboration initiated in 2005. Largest external collaboration to date for BioFocus.
Date of publication: 04/05/2010 Read more
 
PharmaMar presents new trials with three marine-based drugs
The trials provide new information on the drugs' action mechanisms and antitumour potential
Date of publication: 21/04/2010 Read more
 
Biocitech technology park posts record number of partnerships in 2009
Paris life science park residents strike 37 deals with outside companies and continue to increase rate of scientific achievement
Date of publication: 06/04/2010 Read more
 
C21 BioVentures™ 2010 update
Where Early Stage Innovators and Investors Get Deals Done
Date of publication: 05/04/2010 Read more
 
C21 BioVentures™ 2010
Lunch Keynote Presentation by Frederick Frank
Date of publication: 26/03/2010 Read more
 
Novozymes Biopharma announces new study data using Recombumin®
Recombumin® used in protein drug formulation
Date of publication: 24/03/2010 Read more
1 2 Siguiente >